SIPHAT Publishes Third Quarter 2024 Activity Indicators
The Tunisian Pharmaceutical Industries Company, SIPHAT, has released its activity indicators for the third quarter of 2024.
Revenue Performance
The company's revenue for the third quarter of 2024 saw a 15% increase compared to the same period in 2023. However, revenue for the first nine months of 2024 decreased by 11% compared to the same period in 2023.
Export and Paramedical Sales
Notably, SIPHAT did not record any export revenue or paramedical sales in the third quarter of 2024.
Investment Trends
Investment in the third quarter of 2024 decreased by 29% compared to the same period in 2023. On the other hand, investment for the first nine months of 2024 increased by 60% compared to the same period in 2023.
Workforce Update
As of September 30, 2024, SIPHAT had 433 permanent employees, compared to 443 during the same period in 2023, representing a 2% decrease.
